Joint Salvage Using Sandwich Technique for Giant Cell Tumors around Knee

Abstract

The most common site for giant cell tumors (GCT) is knee, where the tumor characteristically extends right up to the subarticular bone plate. Extensive curettage with preservation of the joint should be done wherever possible. The alternatives for filling the void left after curettage are either bone graft or bone cement. Sandwich technique uses the advantages of both, taking care to prevent damage to articular cartilage. This study was done to evaluate the results of sandwich technique in tumors around the knee joint. It was a prospective study of 26 consecutive patients (15 females and 11 males) with Campanacci grade II and grade III GCT around the knee, which qualified the inclusion criterion and underwent knee reconstruction with sandwich technique, after extended curettage of the tumor. The mean age of the patients at the time of surgery was 32.73 ± 11.30 years (range, 18–62 years), and the mean follow-up was 3.87 ± 1.26 years (range, 6.5–2 years). At final follow-up, the functional evaluation was done using Musculoskeletal Tumor Society (MSTS) score and measuring range of motion around the knee. Three patients had recurrence of tumor; in one case, we were able to salvage the joint and repeat sandwich surgery was performed, and in the other two cases, the joint was breached; therefore, we resorted to resection arthrodesis. At final follow-up, the mean functional arc of motion around the knee and the mean MSTS score in patients without arthrodesis was 123.52 ± 10.21 degrees (range, 100–130 degrees) and 27.04/30, respectively; all patients were able to do their activities of daily living with ease. Sandwich technique is a good reconstruction procedure in GCT around knee joint with good survival rate, minimal complications, and good functional outcome.

Keywords

giant cell tumors - sandwich technique - knee

• References

• 1 Turcotte RE, Wunder JS, Isler MH , et al; Canadian Sarcoma Group. Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res 2002; (397) 248-258
• 2 Wang HC, Chien SH, Lin GT. Management of grade III giant cell tumors of bones. J Surg Oncol 2005; 92 (1) 46-51
• 3 Lausten GS, Jensen PK, Schiødt T, Lund B. Local recurrences in giant cell tumour of bone. Long-term follow up of 31 cases. Int Orthop 1996; 20 (3) 172-176
• 4 Szendröi M. Giant-cell tumour of bone. J Bone Joint Surg Br 2004; 86 (1) 5-12
• 5 Niu X, Zhang Q, Hao L , et al. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution. J Bone Joint Surg Am 2012; 94 (5) 461-467
• 6 Goodman HJ, Benevenia J. Adjuvant treatment of non-malignant active and aggressive bone tumors. Curr Orthop Pract 2009; 20 (6) 610-615
• 7 Blackley HR, Wunder JS, Davis AM, White LM, Kandel R, Bell RS. Treatment of giant-cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg Am 1999; 81 (6) 811-820
• 8 Turcotte RE. Giant cell tumor of bone. Orthop Clin North Am 2006; 37 (1) 35-51
• 9 Becker WT, Dohle J, Bernd L , et al; Arbeitsgemeinschaft Knochentumoren. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. J Bone Joint Surg Am 2008; 90 (5) 1060-1067
• 10 Capanna R, Fabbri N, Bettelli G. Curettage of giant cell tumor of bone. The effect of surgical technique and adjuvants on local recurrence rate. Chir Organi Mov 1990; 75 (1, Suppl): 206
• 11 Vult von Steyern F, Bauer HC, Trovik C , et al; Scandinavian Sarcoma Group. Treatment of local recurrences of giant cell tumour in long bones after curettage and cementing. A Scandinavian Sarcoma Group study. J Bone Joint Surg Br 2006; 88 (4) 531-535
• 12 Tejwani SG, Hame SL, Eckardt JJ. Subchondral giant-cell tumor of the proximal tibia: arthroscopic treatment for accelerated articular cartilage and meniscal degeneration in two patients. Arthroscopy 2004; 20 (6) 644-649
• 13 Puri A, Agarwal M. Treatment of giant cell tumor of bone: Current concepts. Indian J Orthop 2007; 41 (2) 101-108
• 14 Kivioja AH, Blomqvist C, Hietaniemi K , et al. Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop 2008; 79 (1) 86-93
• 15 Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am 1987; 69 (1) 106-114
• 16 Remedios D, Saifuddin A, Pringle J. Radiological and clinical recurrence of giant-cell tumour of bone after the use of cement. J Bone Joint Surg Br 1997; 79 (1) 26-30
• 17 Pettersson H, Rydholm A, Persson B. Early radiologic detection of local recurrence after curettage and acrylic cementation of giant cell tumours. Eur J Radiol 1986; 6 (1) 1-4
• 18 Heck Jr RK. Benign/aggressive tumours of bone. In: Canale ST, Beaty JH, , eds. Campbell's Operative Orthopaedics. 11th ed. Philadelphia: Elsevier; 2008: 883-900
• 19 Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res 1993; (286) 241-246
• 20 Kapoor SK, Tiwari A. Resection arthrodesis for giant cell tumors around the knee. Indian J Orthop 2007; 41 (2) 124-128
• 21 Muscolo DL, Ayerza MA, Aponte-Tinao LA, Ranalletta M. Use of distal femoral osteoarticular allografts in limb salvage surgery. J Bone Joint Surg Am 2005; 87 (11) 2449-2455
• 22 Mankin HJ, Hornicek FJ. Treatment of giant cell tumors with allograft transplants: a 30-year study. Clin Orthop Relat Res 2005; 439 (439) 144-150
• 23 Algawahmed H, Turcotte R, Farrokhyar F, Ghert M. High-speed burring with and without the use of surgical adjuvants in the intralesional management of giant cell tumor of bone: a systematic review and meta-analysis. Sarcoma 2010; 2010: pii: 586090
• 24 Leeson MC, Lippitt SB. Thermal aspects of the use of polymethylmethacrylate in large metaphyseal defects in bone. A clinical review and laboratory study. Clin Orthop Relat Res 1993; (295) 239-245
• 25 Prosser GH, Baloch KG, Tillman RM, Carter SR, Grimer RJ. Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone?. Clin Orthop Relat Res 2005; (435) 211-218
• 26 Hirn M, de Silva U, Sidharthan S , et al. Bone defects following curettage do not necessarily need augmentation. Acta Orthop 2009; 80 (1) 4-8
• 27 Saha S, Pal S. Improvement of mechanical properties of acrylic bone cement by fiber reinforcement. J Biomech 1984; 17 (7) 467-478
• 28 Mjöberg B, Pettersson H, Rosenqvist R, Rydholm A. Bone cement, thermal injury and the radiolucent zone. Acta Orthop Scand 1984; 55 (6) 597-600
• 29 Nelson DA, Barker ME, Hamlin BH. Thermal effects of acrylic cementation at bone tumour sites. Int J Hyperthermia 1997; 13 (3) 287-306
• 30 von Steyern FV, Kristiansson I, Jonsson K, Mannfolk P, Heinegård D, Rydholm A. Giant-cell tumour of the knee: the condition of the cartilage after treatment by curettage and cementing. J Bone Joint Surg Br 2007; 89 (3) 361-365
• 31 van der Heijden L, van de Sande MA, Heineken AC, Fiocco M, Nelissen RG, Dijkstra PD. Mid-term outcome after curettage with polymethylmethacrylate for giant cell tumor around the knee: higher risk of radiographic osteoarthritis?. J Bone Joint Surg Am 2013; 95 (21) e159
• 32 Persson BM, Ekelund L, Lövdahl R, Gunterberg B. Favourable results of acrylic cementation for giant cell tumors. Acta Orthop Scand 1984; 55 (2) 209-214
• 33 Ayerza MA, Aponte-Tinao LA, Farfalli GL, Restrepo CA, Muscolo DL. Joint preservation after extensive curettage of knee giant cell tumors. Clin Orthop Relat Res 2009; 467 (11) 2845-2851
• 34 Gaston CL, Bhumbra R, Watanuki M , et al. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?. J Bone Joint Surg Br 2011; 93 (12) 1665-1669
• 35 Arkill KP, Winlove CP. Solute transport in the deep and calcified zones of articular cartilage. Osteoarthritis Cartilage 2008; 16 (6) 708-714
• 36 Malinin T, Ouellette EA. Articular cartilage nutrition is mediated by subchondral bone: a long-term autograft study in baboons. Osteoarthritis Cartilage 2000; 8 (6) 483-491
• 37 Bucholz RW. Nonallograft osteoconductive bone graft substitutes. Clin Orthop Relat Res 2002; (395) 44-52
• 38 Bauer TW, Muschler GF. Bone graft materials. An overview of the basic science. Clin Orthop Relat Res 2000; 200 (371) 10-27
• 39 Abdelrahman M, Bassiony AA, Shalaby H, Assal MK. Cryosurgery and impaction subchondral bone graft for the treatment of giant cell tumor around the knee. HSS J 2009; 5 (2) 123-128
• 40 Banerjee S, Sabui KK, Chatterjee R, Das AK, Mondal J, Pal DK. Sandwich reconstruction technique for subchondral giant cell tumors around the knee. Curr Orthop Pract 2012; 23 (5) 459-466
• 41 Zhen W, Yaotian H, Songjian L, Ge L, Qingliang W. Giant-cell tumour of bone. The long-term results of treatment by curettage and bone graft. J Bone Joint Surg Br 2004; 86 (2) 212-216
• 42 Ghert MA, Rizzo M, Harrelson JM, Scully SP. Giant-cell tumor of the appendicular skeleton. Clin Orthop Relat Res 2002; (400) 201-210
• 43 O'Donnell RJ, Springfield DS, Motwani HK, Ready JE, Gebhardt MC, Mankin HJ. Recurrence of giant-cell tumors of the long bones after curettage and packing with cement. J Bone Joint Surg Am 1994; 76 (12) 1827-1833